Missense mutation of the reticulon-4 receptor alters spatial memory and social interaction in mice

Behavioural Brain Research

Volumn 224, Issue 1, 2011, Pages 73-79

  Lazar, Noah L ^a   Singh, Shiva ^a   Paton, Tara ^b   Clapcote, Steven J ^c   Gondo, Yoichi ^d   Fukumura, Ryutaro ^d   Roder, John C ^e   Cain, Donald P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d RIKEN   (Japan)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Mouse model; PPI; Reticulon 4 receptor; Schizophrenia; Social interaction; Spatial cognition

Indexed keywords

MEMBRANE PROTEIN; NOGO 66 RECEPTOR; RETICULON 4 RECEPTOR; UNCLASSIFIED DRUG;

ACOUSTIC REFLEX; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; COGNITION; CONTROLLED STUDY; GENE; GENE MAPPING; GENETIC VARIABILITY; LATENT PERIOD; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; RTN4R GENE; SCHIZOPHRENIA; SENSORY GATING; SEQUENCE ALIGNMENT; SOCIAL INTERACTION; SPATIAL MEMORY;

ACOUSTIC STIMULATION; ANIMALS; ARGININE; BEHAVIOR, ANIMAL; GPI-LINKED PROTEINS; HISTIDINE; INHIBITION (PSYCHOLOGY); INTERPERSONAL RELATIONS; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION, MISSENSE; MYELIN PROTEINS; RECEPTORS, CELL SURFACE; REFLEX, ACOUSTIC;

EID: 79959197542     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.05.020     Document Type: Article

References (45)

1. Lopez A.D., Murray C.C. The global burden of disease, 1990-2020. Nat Med 1998, 4:1241-1243.
2. Barnes T.R., McEvedy C.J., Nelson H.E. Management of treatment resistant schizophrenia unresponsive to clozapine. Br J Psychiatry Suppl 1996, 31-40.
3. Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am 2007, 30:511-533.
4. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411.
5. Karayiorgou M., Gogos J.A. The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 2004, 132:95-104.
6. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part II: schizophrenia. Am J Hum Genet 2003, 73:34-48.
7. Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S., et al. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci 2008, 28:13161-13172.
8. Hsu R., Woodroffe A., Lai W.S., Cook M.N., Mukai J., Dunning J.P., et al. Nogo receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS One 2007, 2:e1234.
9. Meng J., Shi Y., Zhao X., Guo S., Wang H., Zheng Y., et al. No association between the genetic polymorphisms in the RTN4R gene and schizophrenia in the Chinese population. J Neural Transm 2007, 114:249-254.
10. Sinibaldi L., De L.A., Bellacchio E., Conti E., Pasini A., Paloscia C., et al. Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum Mutat 2004, 24:534-535.
11. Voineskos A.N. Converging evidence for the Nogo-66 receptor gene in schizophrenia. J Neurosci 2009, 29:5045-5047.
12. Niederost B., Oertle T., Fritsche J., McKinney R.A., Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 2002, 22:10368-10376.
13. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002, 22:5505-5515.
14. Fournier A.E., Gould G.C., Liu B.P., Strittmatter S.M. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 2002, 22:8876-8883.
15. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001, 409:341-346.
16. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., et al. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiatry 2002, 159:2000-2006.
17. Hunt D., Mason M.R., Campbell G., Coffin R., Anderson P.N. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002, 20:537-552.
18. Josephson A., Trifunovski A., Widmer H.R., Widenfalk J., Olson L., Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002, 453:292-304.
19. Joyal C.C., Laakso M.P., Tiihonen J., Syvalahti E., Vilkman H., Laakso A., et al. The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients. Biol Psychiatry 2003, 54:1302-1304.
20. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999, 45:17-25.
21. Selemon L.D., Kleinman J.E., Herman M.M., Goldman-Rakic P.S. Smaller frontal gray matter volume in postmortem schizophrenic brains. Am J Psychiatry 2002, 159:1983-1991.
22. Barton W.A., Liu B.P., Tzvetkova D., Jeffrey P.D., Fournier A.E., Sah D., et al. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 2003, 22:3291-3302.
23. Crawley J.N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 1997, 31:197-211.
24. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
25. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
26. Crawley J.N., Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 2004, 10:248-258.
27. Dawson M.E., Schell A.M., Hazlett E.A., Nuechterlein K.H., Filion D.L. On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia. Psychiatry Res 2000, 96:187-197.
28. Deacon R.M., Rawlins J.N. Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav Neurosci 2002, 116:472-478.
29. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302.
30. Sams-Dodd F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 1995, 6:55-65.
31. Sams-Dodd F. Effects of continuous d-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology 1998, 19:18-25.
32. Sakuraba Y., Sezutsu H., Takahasi K.R., Tsuchihashi K., Ichikawa R., Fujimoto N., et al. Molecular characterization of ENU mouse mutagenesis and archives. Biochem Biophys Res Commun 2005, 336:609-616.
33. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002, 30:3894-3900.
34. Ouagazzal A.M., Reiss D., Romand R. Effects of age-related hearing loss on startle reflex and prepulse inhibition in mice on pure and mixed C57BL and 129 genetic background. Behav Brain Res 2006, 172:307-315.
35. Gogos J.A., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 1999, 21:434-439.
36. Lazar N.L., Rajakumar N., Cain D.P. Injections of NGF into neonatal frontal cortex decrease social interaction as adults: a rat model of schizophrenia. Schizophr Bull 2008, 34:127-136.
37. Beiko J., Lander R., Hampson E., Boon F., Cain D.P. Contribution of sex differences in the acute stress response to sex differences in water maze performance in the rat. Behav Brain Res 2004, 151:239-253.
38. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
39. Cain D.P., Boon F., Corcoran M.E. Thalamic and hippocampal mechanisms in spatial navigation: a dissociation between brain mechanisms for learning how versus learning where to navigate. Behav Brain Res 2006, 170:241-256.
40. Kallai J., Makany T., Csatho A., Karadi K., Horvath D., Kovacs-Labadi B., et al. Cognitive and affective aspects of thigmotaxis strategy in humans. Behav Neurosci 2007, 121:21-30.
41. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994, 61:59-64.
42. Pogue-Geile M.F., Gottesman I.I. Schizophrenia: study of a genetically complex phenotype. Neurobehavioral genetics: methods and applications 1999, 247-264. CRC Press, New York, NY. B.C. Jones, P. Mormede (Eds.).
43. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 1998, 55:67-74.
44. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54:387-402.
45. Gondo Y. Trends in large-scale mouse mutagenesis: from genetics to functional genomics. Nat Rev Genet 2008, 9:803-810.